Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The webpage has been updated to include new results and definitions related to the clinical study of pembrolizumab treatment in patients with acral lentiginous melanoma, while previous results and definitions have been removed.
    Difference
    7%
    Check dated 2025-04-23T22:17:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study criteria for a clinical trial on acral lentiginous melanoma and the addition of a new revision number.
    Difference
    44%
    Check dated 2025-04-16T14:42:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.14.3 to v2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:08:37.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    51 days ago
    Change Detected
    Summary
    The page now indicates that results have been submitted, replacing the previous message that no results were posted.
    Difference
    0.1%
    Check dated 2025-03-11T04:44:28.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T21:13:22.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T10:24:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.